Investigation on efficacy of memantine in patients with Alzheimer's disease.
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2017
Price : $35 *
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 09 Nov 2017 Status changed from recruiting to completed.
- 13 Aug 2013 New trial record